The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Blood Biomarkers for the Diagnosis of Neurodegenerative Dementia: A Systematic Review
Abstract
Importance Accurately diagnosing neurodegenerative dementia is often challenging due to overlapping clinical features. Disease specific biomarkers could enhance diagnostic accuracy. However, CSF analysis procedures and advanced imaging modalities are either invasive or high-priced, and routinely unavailable. Easily accessible disease biomarkers would be of utmost value for accurate differential diagnosis of dementia subtypes. Objective To assess the diagnostic accuracy of blood-based biomarkers for the differential diagnosis of AD from Frontotemporal Lobar Degeneration (FTLD), or AD from Dementia with Lewy Bodies (DLB). Methods Systematic review. Three databases (PubMed, Scopus, and Web of Science) were searched. Studies assessing blood-based biomarkers levels in AD versus FTLD, or AD versus DLB, and its diagnostic accuracy, were selected. When the same biomarker was assessed in three or more studies, a meta-analysis was performed. QUADAS-2 criteria were used for quality assessment. Results Twenty studies were included in this analysis. Collectively, 905 AD patients were compared to 1262 FTLD patients, and 209 AD patients were compared to 246 DLB patients. Regarding biomarkers for AD versus FTLD, excellent discriminative accuracy (AUC >0.9) was found for p-tau181, p-tau217, synaptophysin, synaptopodin, GAP43 and calmodulin. Other biomarkers also demonstrated good accuracy (AUC = 0.8-0.9). For AD versus DLB distinction, only miR-21-5p and miR-451a achieved excellent accuracy (…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Further, biomarkers relevant for bvFTD, such as neurofilament light chain in CSF and synaptic proteins such as Synaptophysin and GAP4398, 99, 100 were not available.”
From Altered spatiotemporal brain dynamics of interoception in behavioural-variant frontotemporal dementia (2025) · cites this paper as [98]
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · cited 1×
“In fact, one study(24) reported ∼20% of AD misdiagnosed as FTLD subtypes and DLB, following validated McKhann criteria.(20) Another study found that current DLB clinical criteria also failed accurate diagnosis in ∼20% of the cases, with AD representing the greatest concern regarding misdiagnosis.”
BackgroundQUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735 · cited 1×
“The Wan et al method was used to estimate the mean and standard deviation (SD), when studies provided median and interquartile range (IQR).(46) Additionally, when standard error of the mean (SEM) was reported rather than standard deviation (SD), conversion to SD was made following Cochrane Handbook for Systematic Revi…”
MethodSensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411 · cited 1×
“AD diagnostic criteria include the analysis of core cerebrospinal fluid (CSF) biomarkers, which require lumbar puncture, or advanced imaging techniques, such as positron emission tomography (PET).(32,33) However, these methods may be invasive or inconvenient, or very expensive, especially for disease monitoring.”
MethodThe neuropathological diagnosis of Alzheimer's disease
DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Research works printed but not linked: 5
- Finger EC, 2016, Continuum, 22, 464
- Gomperts SN, 2016, Continuum (Minneap Minn), 22, 435
- Higgins JPT LT, 2022, Cochrane Handbook for Systematic Reviews of Interventions version 63
- Ritchie C, 2017, Cochrane Database Syst Rev, 3, Cd010803
- Kasuga K, 2012, Int J Alzheimers Dis, 2012, 437025
Cited by
Eratne, D., Kang, M. J., Lewis, C. C., Dang, C., Malpas, C. B., Keem, M. H., Grewal, J. K., Marinov, V., Coe, A., Kaylor‐Hughes, C., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14278 · Cited by 31
Blood-Based Biomarkers in Frontotemporal Dementia: A Narrative Review
Liampas, I., Kyriakoulopoulou, P., Karakoida, V., Kavvoura, P. A., Sgantzos, M. N., Bogdanos, D. P., Stamati, P., Dardiotis, E., & Siokas, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111838 · Cited by 25
“Apart from the evaluation of single biomarkers, their combination constitutes an intriguing prospect in the field of neurodegeneration [104].”
BackgroundResultVasileva-Metodiev, S. Z., Spargo, D. J., Klein, E., Quevenco, F., Cotton, S. E., Sánchez‐Juan, P., Niimi, Y., & Fowler, N. R. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251322978 · Cited by 21
Chatzidimitriou, E., Ntritsos, G., Lagoudaki, R., Poptsi, E., Tsardoulias, E., Symeonidis, A. L., Tsolaki, M., Konstantinopoulou, E., Papadopoulou, K., Charalambous, P., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15100466 · Cited by 16
Hazelton, J. L., Della Bella, G., Barttfeld, P., Dottori, M., Gonzalez-Gomez, R., Migeot, J., Moguilner, S., Legaz, A., Hernandez, H., Prado, P., et al. (2025) · eBioMedicine · doi:10.1016/j.ebiom.2025.105614 · Cited by 14
“94 – 97 Further, biomarkers relevant for bvFTD, such as neuro fi lament light chain in CSF and synaptic proteins such as Syn-aptophysin and GAP43 98 – 100 were not available.”
Metadata
- Authors
- Santos, F., Cabreira, V., Rocha, S., & Massano, J.
- Affiliations
- Universidade do Porto (PT)
- Corresponding author
- Massano, João
- Venue
- Journal of Geriatric Psychiatry and Neurology
- Publisher
- SAGE Publications
- Published
- 2022-11-24
- Volume
- 36
- Issue
- 4
- Pages
- 267-281
- ISSN
- 0891-9887 (ISSN-L)
- 1552-5708
- OpenAlex
- W4309889932
- Cited by
- 24
- References
- 141
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 5 · 2023: 2
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Geriatric Psychiatry and Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- blood biomarkers, neurodegenerative dementia, Alzheimer's disease, frontotemporal lobar degeneration, dementia with Lewy bodies, differential diagnosis, diagnostic accuracy, phosphorylated tau, synaptophysin, synaptopodin, GAP-43, calmodulin, microRNA, miR-21-5p, miR-451a
- MeSH terms
- Alzheimer Disease, Diagnosis, Differential, Humans, Prospective Studies, Biomarkers, Amyloid beta-Peptides, tau Proteins, Lewy Body Disease, MicroRNAs, Frontotemporal Lobar Degeneration, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blood Biomarkers for the Diagnosis of Neurodegenerative Dementia: A Systematic Review. https://app.cochat.ai/papers/10.1177/08919887221141651
- The paper
- Santos, F., Cabreira, V., Rocha, S., & Massano, J. (2023). Blood Biomarkers for the Diagnosis of Neurodegenerative Dementia: A Systematic Review. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/08919887221141651
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.